Globus Medical Inc
GMED· NYSE
GMEDGlobus Medical Inc
Released Nov 5, 2024, after the close
10-Q filed Nov 5, 2024, 36 days after period end · 0001562762-24-000254
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $625.71M | $383.64M | $254.15M | $229.72M |
| Net Income | $51.84M | $998.00K | $47.43M | $47.21M |
| EPS Diluted |
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR
| $0.38 |
| $0.01 |
| $0.47 |
| $0.45 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
